Hai Chen Pharmaceutical (300584.SZ) announced its performance in the first half of the year, with a net profit attributable to shareholders of 29.1577 million yuan, an increase of 17.87%

Financial news from the Wise Financial APP, Hailong Pharmaceutical (300584.SZ) released its 2025 semi-annual report. The company's operating income was 309 million yuan, an increase of 30.46% year-on-year. The net profit attributable to shareholders of the listed company was 29.1577 million yuan, an increase of 17.87% year-on-year. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 28.851 million yuan, an increase of 13.07% year-on-year. Basic earnings per share were 0.243 yuan.